Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAY.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAY.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.25.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.25.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.25.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.25.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.25.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.25.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJ.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBJ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XBJ.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBJ.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBJ.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBJ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EP.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EP.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EP.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EP.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used